Skip to content
MarketScale
‹ Back to IndustriesHealthcare

SaaS in Healthcare Implements Technology without the Hassles, Headaches, or Additional Costs

Healthcare providers can now access enterprise-grade technology without the capital investment or internal infrastructure burden

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Mike Tracy · Healthcare SolutionsHealthcare TechnologyMike TraceySaas in Healthcare
Share

Key takeaways

01

Healthcare providers can now access enterprise-grade technology without the capital investment or internal infrastructure burden

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

In a healthcare landscape where the prohibitive costs of technology can often impede progress, how does Software as a Service (SaaS) emerge as a cost-effective solution to bridge this gap and enhance patient care?

Addressing this critical issue, Mike Tracy, a C-Level Healthcare Operations Strategist with over 20 years of experience, notes the transformative impact of SaaS in healthcare.

"Software as a Service has become the alternative to implementing technology on your own," Tracy says. "It allows providers to leverage the best technology in the marketplace at a price point that is affordable and meets their needs depending on the size of the provider."

It allows providers to leverage the best technology in the marketplace at a price point that is affordable and meets their needs depending on the size of the provider.
— Mike Tracy, C-Level Healthcare Operations Strategist

Regarding data and analytics, Tracey sees SaaS offerings as a true all-in-one solution.

"Software as a Service allows you to make sure you have all of your data in one place, one source of truth, to feed those AI models and allow for things like predictive analytics, which then allows you to do proactive outreach to members, to then help with preventative care, or to determine what actions are likely to happen next so that you can be advising your patient where they need to be, what they need to do before they’re even asking the question."

Software as a Service allows you to make sure you have all of your data in one place, one source of truth, to feed those AI models and allow for things like predictive analytics, which then allows you to do proactive outreach to members, to then help with preventative care, or to determine what actions are likely to happen next so that you can be advising your patient where they need to be, what they need to do before they’re even asking the question.
— Mike Tracy, C-Level Healthcare Operations Strategist

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Mike Tracy
Mike TracyChief Operating Officer at enGen

With a fulfilling history within the healthcare industry, Mike establish thoughtful, metric-based direction for new and improved initiatives, processes, and programs to refresh employee engagement, satisfy customers, and revamp operational efficiencies. By employing effective cost analysis, he identify avenues for appropriate cost reductions without jeopardizing staffing and operation needs. For example, Mike accomplished a 20% reduction in SG&A cost for technology by engineering a standard operating model, automation development, and revising processes in my current position. Alongside expert cost analysis, he ensure all implementations align with company goals and missions while assessing community needs.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

Mike Tracy
Mike Tracy

Chief Operating Officer at enGen

With a fulfilling history within the healthcare industry, Mike establish thoughtful, metric-based direction for new and improved initiatives, processes, and programs to refresh employee engagement, satisfy customers, and revamp operational efficiencies. By employing effective cost analysis, he identify avenues for appropriate cost reductions without jeopardizing staffing and operation needs. For example, Mike accomplished a 20% reduction in SG&A cost for technology by engineering a standard operating model, automation development, and revising processes in my current position. Alongside expert cost analysis, he ensure all implementations align with company goals and missions while assessing community needs.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512